| Model Number |
GELSOFT DOUBLE BIFURCATE |
| Medical Device Problem Code |
Material Integrity Problem (2978)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/25/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The site advised that the device is not available; therefore no evaluation of the graft was possible.(b)(4).Review of similar complaints of leakage for all gelsoft branded devices gave an occurrence rate of b4.Additional information was requested from the clinician regarding the procedure.A review of the retained qc and manufacturing records for this batch (with attention to all in process and base material porosity testing) confirmed that the batch was manufactured to its design specification.The site advised that the device is not available.No issue was found with the manufacturing of the batch (based on the review of the retained production records).The root cause of the reported defect could not be determined.Vascutek ltd.Considers this event as closed.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process, if an adverse trend develops action may be taken at that time.
|
| |
|
Event or Problem Description
|
|
Vascutek ltd.S (b)(4) distribution partner ((b)(4)) reported an incidence of blood leakage of a gelsoft bifurcate graft.The graft was originally implanted on (b)(6) 2019.The patient underwent a laparotomy procedure on (b)(6) 2021 for the removal of a pseudo aneurysm; it was noted after the removal of the aneurysm blood leakage was observed from the in-situ gelsoft graft.The event was reported to vascutek ltd.As possibly device related.
|
| |
|
Search Alerts/Recalls
|